Searched for
SANOFI TB DRUG
MNC pharma companies: Time to take a re-look? 8 pharma stocks, 5 with an upside of up to 34%Some time back an MNC pharma firm announced the divestment of one of its businesses in India. Another sold one of its plants. Now, with the...- MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...
- MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...
- Indian companies have made a comeback. Will MNCs be able to do it ? 7 MNC pharma stocks with upside potential of up to 21%While they still trade at premium valuations, they have not created wealth for shareholders. The fact is an age-old theory that just having...
- Will the wave of restructuring help? 7 MNC pharma stocks with upside potential of up to 14%In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of thes...
- Pharma Industry staring at 30-40 bps hit on updated NLEMManchanda added that the anti-infectives treating HIV, TB and drug cessation treatments in the list doesn't have a major impact on margins ...
- Lockdown, Day 17: Death toll crosses 200-mark, no community transmission yetThere has been no sign of community transmission yet, the Health ministry said even as India's Covid numbers inched closer to the 7,000-mar...
- Regulator waives off clinical trials, clears Sanofi TB Drug“We have recently received final approval for rifapentine from the Indian regulatory authorities. Rifapentine is now officially registered ...
- Regulator waives off clinical trials, clears Sanofi TB drugIndia carries the highest burden of TB with about 2.69 mn cases in 2018. About 40% of the country’s population is estimated to have latent ...
- Sanofi inks pact with Unitaid; to reduce TB drug Rifapentine price by 70%In a landmark development, global biopharmaceutical company Sanofi will lower the price of Rifapentine, a critically important drug used to...
- Price cut: Drug makers' profitability may come under pressureLast week, NPPA announced that it plans to bring an additional 50 drugs belonging to the cardiovascular and anti-diabetic segment under pri...
- Pharmaceutical companies like Ranbaxy Laboratories, Sanofi India and others fume at price control orderOn Friday, the National Pharmaceutical Pricing Authority (NPPA) slashed the prices of 108 brands under a provision of the Drug Pricing Cont...
- Lupin gets USFDA nod for tuberculosis drugDrug major Lupin said it has received US health regulator's approval to market a generic version of Sanofi Aventis' Rifadin capsules.
- Glaxo's bird flu drug to hit market next yearA bird flu vaccine for humans that uses only a very low dose of active ingredient has proved effective in clinical tests and could be mass ...
Load More
